Wall Street Slides as Iran Peace Hopes Fade Oil Surges Past Key Levels Indian Government Bonds Pare Gains on Report of RBI Rate Hike Consideration to Stem Rupee Weakness Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles in Push for Higher Returns Bridgeline BLIN Q1 2026 Earnings What Went Wrong and Whats Next Grenzebach Establishes Standalone Additive Manufacturing Business Unit GameSquare Holdings Receives Amended Schedule 13D Filing Consumer Prices Rise 38 in April Surpassing Expectations and Marking a 11Month High Shell SHEL Upgraded to Buy Following Transaction with ARC Resources Tesla Launches Full SelfDriving Supervised in China After Regulatory Hurdles Facing Intense Local Competition SpaceX Files for Stock Market Debut Under Ticker SPCX Potentially Elevating Elon Musk to Trillionaire Status MTVA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline MLSS Q1 2026 Earnings NarrowerThanExpected Loss Per Share Maplebear Inc CART Q1 2026 Earnings Earnings Miss Expectations Amid Quiet Revenue Disclosures Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines ArcBest ARCB Q1 2026 Earnings EPS Surges Past Estimates in Modest Volume Environment Anterix ATEX Surges Nearly 6 Key Levels in Focus as Spectrum Demand Intensifies United Parks Resorts PRKS Rises 169 Key Levels and Outlook Lucas GC Limited LGCL Nears Key Support After Modest Decline Geron Corporation GERN Edges Higher Testing Key Resistance After Modest Gains Taiwan Stock Market Surpasses India to Become FifthLargest Globally Fueled by TSMC Castle Biosciences Q1 2026 Earnings NarrowerThanExpected Loss Stock Slips CTNM Q1 2026 Earnings Significant EPS Beat Amid Pipeline Progress Stock Slightly Down MGEE Q1 2026 Earnings Earnings Beat Bolsters Utilitys Steady Profile NOG Q1 2026 Earnings EPS Beats Estimates by 789 Stock Declines OKTA Q1 2026 Earnings EPS Beat Drives Positive Market Reaction BIP Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds Cybin Inc HELP Q1 2026 Earnings WiderthanExpected Loss Highlights Clinical Development Costs QuinStreet Q1 2026 Earnings EPS Misses Estimates Stock Gains 24